{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:39:23Z","timestamp":1789155563680,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ygyno.2022.03.018","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:20:48Z","timestamp":1648718448000},"page":"568-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility"],"prefix":"10.1016","volume":"165","author":[{"given":"Lisa M.","family":"Marinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Kisiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth W.","family":"Slettedahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas W.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen A.","family":"Lemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi","family":"Shridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Staub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli N.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calise K.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Doering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Giakoumopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Solsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim T.","family":"Allawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abram M.","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Albright Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Moehlenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracie","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa S.","family":"Deist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kenneth","family":"Schoolmeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie N.","family":"Bakkum-Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2022.03.018_bb0005","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0010","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0015","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajog.2005.05.005","article-title":"Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial","volume":"193","author":"Buys","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0020","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK collaborative trial of ovarian Cancer screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1373\/clinchem.2011.171264","article-title":"Quantification of methylated markers with a multiplex methylation-specific technology","volume":"58","author":"Zou","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13059-018-1492-3","article-title":"Homeobox oncogene activation by pan-cancer DNA hypermethylation","volume":"19","author":"Su","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0040","article-title":"Methylated bone morphogenetic protein 3 (BMP3) gene: evaluation of tumor suppressor function and biomarker potential in biliary cancer","volume":"4","author":"Kisiel","year":"2013","journal-title":"J. Mol. Biomark Diagn"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050114","article-title":"Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis","volume":"5","author":"Chan","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0050","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1073\/pnas.1703577114","article-title":"DNA methylation markers for diagnosis and prognosis of common cancers","volume":"114","author":"Hao","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ebiom.2018.03.029","article-title":"Plasma mSEPT9: a novel circulating cell-free DNA-based epigenetic biomarker to diagnose hepatocellular carcinoma","volume":"30","author":"Oussalah","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0065","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.juro.2016.09.118","article-title":"Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy","volume":"197","author":"van Kessel","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0070","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/pros.23191","article-title":"Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies","volume":"76","author":"Van Neste","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtho.2016.08.123","article-title":"Validation of the SHOX2\/PTGER4 DNA methylation marker panel for plasma-based discrimination between patients with malignant and nonmalignant lung disease","volume":"12","author":"Weiss","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0080","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1158\/1078-0432.CCR-13-2637","article-title":"A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrence","volume":"20","author":"Su","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fcell.2019.00182","article-title":"Epigenetic biomarkers in the management of ovarian cancer: current prospectives","volume":"7","author":"Singh","year":"2019","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal Fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nprot.2010.190","article-title":"Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling","volume":"6","author":"Gu","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0105","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","article-title":"MethPrimer: designing primers for methylation PCRs","volume":"18","author":"Li","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0110","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0115","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.30244","article-title":"Hepatocellular carcinoma detection by plasma methylated DNA: discovery, phase I pilot, and phase II clinical validation","volume":"69","author":"Kisiel","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0120","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1093\/bioinformatics\/bts337","article-title":"SAAP-RRBS: streamlined analysis and annotation pipeline for reduced representation bisulfite sequencing","volume":"28","author":"Sun","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0125","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1158\/1078-0432.CCR-14-2469","article-title":"New DNA methylation markers for pancreatic cancer: discovery, tissue validation, and pilot testing in pancreatic juice","volume":"21","author":"Kisiel","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0130","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2013.04.023","article-title":"Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia","volume":"11","author":"Lidgard","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0135","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1038\/ncomms7184","article-title":"An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma","volume":"6","author":"Chakraborty","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/10799893.2020.1811325","article-title":"Agrin promotes the proliferation, invasion and migration of rectal cancer cells via the WNT signaling pathway to contribute to rectal cancer progression","volume":"41","author":"Wang","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0145","first-page":"64","article-title":"Branched-chain amino acid metabolism in cancer","volume":"21","author":"Ananieva","year":"2018","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41419-021-03456-7","article-title":"BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0155","doi-asserted-by":"crossref","first-page":"97811","DOI":"10.18632\/oncotarget.22083","article-title":"Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT\/mTOR signaling in renal cell carcinoma","volume":"8","author":"Miao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0160","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1111\/j.1582-4934.2012.01559.x","article-title":"Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer","volume":"16","author":"Storr","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044951","article-title":"Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers","volume":"7","author":"Brait","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0170","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1038\/s41388-019-0936-x","article-title":"Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer","volume":"38","author":"Piqu\u00e9","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgz113","article-title":"CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction","volume":"41","author":"Yeung","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0180","doi-asserted-by":"crossref","first-page":"34022","DOI":"10.1038\/srep34022","article-title":"FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid","volume":"6","author":"Kang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1574893615999200530201333","article-title":"Comprehensive analysis reveals GPRIN1 is a potential biomarker for non-sm all cell lung cancer","volume":"16","author":"Jian","year":"2021","journal-title":"Curr. Bioinforma."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0190","first-page":"853","article-title":"G protein regulated inducer of neurite outgrowth 1 is a potential marker for lung cancer prognosis","volume":"34","author":"Zhuang","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12967-020-02474-x","article-title":"Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis","volume":"18","author":"Wang","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0200","article-title":"The identification of specific methylation patterns across different cancers","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0205","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.3748\/wjg.v25.i26.3392","article-title":"Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis","volume":"25","author":"Liang","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007851","article-title":"A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer","volume":"16","author":"Zhang","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0215","doi-asserted-by":"crossref","first-page":"12765","DOI":"10.1073\/pnas.0505484102","article-title":"Inhibition of single minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells","volume":"102","author":"Aleman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028837","article-title":"The role of the transcription factor SIM2 in prostate cancer","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0225","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","article-title":"Role of Src expression and activation in human cancer","volume":"19","author":"Irby","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2022.03.018_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.10.014","article-title":"Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: ready for prime time?","volume":"468","author":"Asante","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1078-0432.CCR-20-2589","article-title":"Novel methylated DNA markers in the surveillance of colorectal cancer recurrence","volume":"27","author":"Xie","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0245","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/1078-0432.CCR-17-3364","article-title":"Detection of gastric Cancer with novel methylated DNA markers: discovery, tissue validation, and pilot testing in plasma","volume":"24","author":"Anderson","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0250","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1158\/1078-0432.CCR-19-0740","article-title":"Discovery, validation, and application of novel methylated DNA markers for detection of esophageal cancer in plasma","volume":"25","author":"Qin","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0255","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/1078-0432.CCR-18-3720","article-title":"Molecular classification of epithelial ovarian cancer based on methylation profiling: evidence for survival heterogeneity","volume":"25","author":"Bodelon","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0260","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/ijms19061559","article-title":"Distinct DNA methylation profiles in ovarian tumors: opportunities for novel biomarkers","volume":"19","author":"Losi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0265","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1158\/1078-0432.CCR-20-0270","article-title":"Methylomic landscapes of ovarian cancer precursor lesions","volume":"26","author":"Pisanic","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0270","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41379-019-0302-0","article-title":"A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases","volume":"32","author":"Meagher","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2022.03.018_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10110433","article-title":"Cell origins of high-grade serous ovarian cancer","volume":"10","author":"Kim","year":"2018","journal-title":"Cancers (Basel)"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822002001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822002001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:49Z","timestamp":1758772849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822002001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0090825822002001"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}